| abstract |
Use of a compound selected from the group consisting of N-methylglycine, a salt of N-methylglycine, an ester of N-methylglycine, alkylated N-methylglycine, and a precursor of N-methylglycine, for the preparation of a medicament for treating a human patient having schizophrenia. |